Cargando…

Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced Autoimmunity

Environmental factors including drugs, mineral oils and heavy metals such as lead, gold and mercury are triggers of autoimmune diseases in animal models or even in occupationally exposed humans. After exposure to subtoxic levels of mercury (Hg), genetically susceptible strains of mice develop an aut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jha, Vibha, Workman, Creg J., McGaha, Tracy L., Li, Liping, Vas, Jaya, Vignali, Dario A. A., Monestier, Marc
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4133201/ https://www.ncbi.nlm.nih.gov/pubmed/25122007 http://dx.doi.org/10.1371/journal.pone.0104484

Ejemplares similares

The extent of metalloproteinase-mediated LAG3 cleavage limits the efficacy of PD1 blockade
por: Andrews, Lawrence P, et al.
Publicado: (2015)

Modulation of Redox Balance Leaves Murine Diabetogenic TH1 T Cells “LAG-3-ing” Behind
por: Delmastro, Meghan M., et al.
Publicado: (2012)

Autoreactive CD8(+) T cells are restrained by an exhaustion-like program that is maintained by LAG3
por: Grebinoski, Stephanie, et al.
Publicado: (2022)

IDO-GCN2 and autophagy in inflammation
por: McGaha, Tracy L.
Publicado: (2015)

Myeloid Responses to Extracellular Vesicles in Health and Disease
por: Makhijani, Priya, et al.
Publicado: (2022)

Remodulation of the tumor microenvironment by regulatory T cells
por: Liu, Chang, et al.
Publicado: (2015)

Amino Acid Transport and Metabolism in Myeloid Function
por: Halaby, Marie Jo, et al.
Publicado: (2021)

Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment
por: Scott, Ellen N., et al.
Publicado: (2021)

Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapy
por: Chuckran, Christopher A, et al.
Publicado: (2020)

LAG-3(+) tumor-infiltrating lymphocytes ameliorates overall survival in triple-negative breast cancer patients
por: Hu, Guoming, et al.
Publicado: (2023)

TLR9/MyD88 signaling is required for class switching to pathogenic IgG2a and 2b autoantibodies in SLE
por: Ehlers, Marc, et al.
Publicado: (2006)

Pathological Tau transmission initiated by binding lymphocyte-activation gene 3
por: Chen, Chan, et al.
Publicado: (2023)

Kinetics of Alloantigen-Specific Regulatory CD4 T Cell Development and Tissue Distribution After Donor-Specific Transfusion and Costimulatory Blockade
por: Tomita, Yusuke, et al.
Publicado: (2016)

Prognostic Value of Lymphocyte-Activation Gene 3 (LAG3) in Cancer: A Meta-Analysis
por: Saleh, Ramy R., et al.
Publicado: (2019)

Regulatory T Cell–Derived TRAIL Is Not Required for Peripheral Tolerance
por: Dadey, Rebekah E., et al.
Publicado: (2021)

LAG-3 expression in tumor microenvironment of triple-negative breast cancer
por: TAHTACI, Gözde, et al.
Publicado: (2022)

Lymphocyte activation gene-3 (LAG3) mRNA and protein expression on tumour infiltrating lymphocytes (TILs) in oesophageal adenocarcinoma
por: Gebauer, Florian, et al.
Publicado: (2020)

Role of Lymphocyte Activation Gene-3 (Lag-3) in Conventional and Regulatory T Cell Function in Allogeneic Transplantation
por: Sega, Emanuela I., et al.
Publicado: (2014)

Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T-cells to Be Suppressed In Vivo
por: Durham, Nicholas M., et al.
Publicado: (2014)

Prognostic Value of Lymphocyte Activation Gene-3 (LAG-3) Expression in Esophageal Squamous Cell Carcinoma
por: Zhang, Yu, et al.
Publicado: (2018)

Lymphocyte Activation Gene 3 (Lag3) Contributes to α-Synucleinopathy in α-Synuclein Transgenic Mice
por: Gu, Hao, et al.
Publicado: (2021)

Update on lymphocyte-activation gene 3 (LAG-3) in cancers: from biological properties to clinical applications
por: Zhao, Lishu, et al.
Publicado: (2022)

LAG-3, a novel lymphocyte activation gene closely related to CD4
Publicado: (1990)

Risk of Colorectal Polyps and Malignancies Among Predominantly Rural Hispanics
por: Orsak, Gabriela, et al.
Publicado: (2018)

An IL-27/Lag3 axis enhances Foxp3(+) regulatory T cell suppressive function and therapeutic efficacy
por: Do, Jeong-su, et al.
Publicado: (2015)

PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice
por: Okazaki, Taku, et al.
Publicado: (2011)

Understanding LAG-3 Signaling
por: Chocarro, Luisa, et al.
Publicado: (2021)

Lymphocyte activation gene 3 (Lag3) expression is increased in prion infections but does not modify disease progression
por: Liu, Yingjun, et al.
Publicado: (2018)

Lymphocyte activation gene 3 (LAG3) protein expression on tumor-infiltrating lymphocytes in aggressive and TP53-mutated salivary gland carcinomas
por: Arolt, Christoph, et al.
Publicado: (2020)

Lymphocyte Activation Gene (LAG)-3 Is Associated With Mucosal Inflammation and Disease Activity in Ulcerative Colitis
por: Slevin, Stephanie M, et al.
Publicado: (2020)

Combinatorial Immunotherapy: PD-1 may not be LAG-ing behind any more
por: Turnis, Meghan E., et al.
Publicado: (2012)

LAG3’s Enigmatic Mechanism of Action
por: Graydon, Colin G., et al.
Publicado: (2021)

Overcoming the LAG3 phase problem
por: Petersen, Jan, et al.
Publicado: (2022)

LAG-3 Blockade with Relatlimab (BMS-986016) Restores Anti-Leukemic Responses in Chronic Lymphocytic Leukemia
por: Sordo-Bahamonde, Christian, et al.
Publicado: (2021)

Clinicopathological significance and prognostic role of LAG3 + tumor-infiltrating lymphocytes in colorectal cancer; relationship with sidedness
por: Tavana, Shirin, et al.
Publicado: (2023)

Return on Investment of Free Colorectal Cancer Screening Tests in a Primarily Rural Uninsured or Underinsured Population in Northeast Texas
por: Orsak, Gabriela, et al.
Publicado: (2019)

Unsung heroes in health education and promotion: How Community Health Workers contribute to hypertension management
por: Bush, Kim, et al.
Publicado: (2023)

Eftilagimod alpha, a soluble lymphocyte activation gene-3 (LAG-3) protein plus pembrolizumab in patients with metastatic melanoma
por: Atkinson, Victoria, et al.
Publicado: (2020)

Double negative T cells mediate Lag3-dependent antigen-specific protection in allergic asthma
por: Tian, Dan, et al.
Publicado: (2019)

T cell activation and anti-tumor efficacy of anti-LAG-3 antibodies is independent of LAG-3 – MHCII blocking capacity
por: Cemerski, Saso, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_66hstid3gs046kitkqskm23ek4